AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
Pharmaceutical Technology -

AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect remains unknown.

Related Articles

Latest in News

More from Pharmaceutical Technology | Drug Development Vaccine AstraZeneca Serum Institute Of India